Clazosentan in Aneurysmal Subarachnoid Hemorrhage

Stopped Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2)

Conditions

• Aneurysmal Subarachnoid Hemorrhage

Interventions

• DRUG: Clazosentan 5 m/h
• DRUG: Clazosentan 15 mg/h
• DRUG: Placebo

Sponsor

Idorsia Pharmaceuticals Ltd.